Intellectual Property and Business Development Committee
The MaineHealth Intellectual Property and Business Development Committee is appointed by the Chief Academic Officer with approval from the MaineHealth Chief Executive Officer, MaineHealth President and Maine Medical Center President.
The Committee is responsible for the following:
- Making recommendations on whether and/or how much of MaineHealth resources to invest to support the development of an invention
- When to license, to whom, and for how much: or to sell outright, if possible.
- Whether to take ownership position in a company that will develop/market as part of license fee
Intellectual Property and Business Development Committee
Susan Ahern
VP of Innovation, MaineHealth
Chair
Brady Bohrmann
Managing Director, Avalon Ventures
Committee Member
Britt Crewse
Southern Region President, MaineHealth
Executive Sponsor
Robert Frank
Counsel – Special Projects, MaineHealth
Committee Member
Tom Gridley, PhD
Faculty Scientist III, MaineHealth Institute for Research
Committee Member
Beth Kelsch
General Counsel, MaineHealth
Committee Member
Robert King
Former Investor, Goldman Sachs
Committee Member
Adrian Moran
Chief Medical and Transformation Officer, MaineHealth
Committee Member
Andy Mueller, MD
CEO, MaineHealth
Executive Sponsor
Dan Nigrin, MD
Chief Information Officer, MaineHealth
Committee Member
Rich Parker, MS, CBET
Vice President Sales USA, PT MedTech
Committee Member
Doug Sawyer, MD, PhD
Chief Academic Officer & Interim Chief Medical Officer, MaineHealth
Executive Sponsor
Al Swallow III
Chief Financial Officer, MaineHealth
Committee Member
Stuart Watson
Entrepreneur & Board of Trustees member, MaineHealth Maine Medical Center & MaineHealth
Committee Member
David Yarin
Alliance Manager, Music Partnerships
Committee Member